浙江大学学报(医学版)
浙江大學學報(醫學版)
절강대학학보(의학판)
JOURNAL OF ZHEJIANG UNIVERSITY MEDICAL SCIENCES
2009年
6期
598-604
,共7页
蔡蓓蕾%黄雪琴%董晓武%方三华%卢韵碧%张纬萍%胡永洲%魏尔清
蔡蓓蕾%黃雪琴%董曉武%方三華%盧韻碧%張緯萍%鬍永洲%魏爾清
채배뢰%황설금%동효무%방삼화%로운벽%장위평%호영주%위이청
半胱氨酸/遗传%受体%白三烯/遗传%半胱氨酰白三烯%CysLT_2受体%受体拮抗剂%钙离子%C6细胞
半胱氨痠/遺傳%受體%白三烯/遺傳%半胱氨酰白三烯%CysLT_2受體%受體拮抗劑%鈣離子%C6細胞
반광안산/유전%수체%백삼희/유전%반광안선백삼희%CysLT_2수체%수체길항제%개리자%C6세포
Cysteine/genet%Receptors%leukotriene/genet%Cysteinyl leukotriene%CysLT_2 receptor%receptor antagonist%Calcium%C6 cells
目的:建立半胱氨酰白三烯受体2(CysLT_2受体)拮抗剂筛选的细胞模型及方法,初筛系列合成化合物.方法:选用高表达CysLT_2受体的大鼠C6胶质瘤细胞,激动剂LTD_4攻击后检测细胞内钙浓度变化,作为CysLT_2受体拮抗剂的筛选方法,初步筛选有拮抗剂活性的化合物.采用CysLT1/CysLT_2受体非选择性拮抗剂Bay u9773和CysLT_2受体选择性拮抗剂AP-100984作为参照.结果:RT-PCR鉴定表明C6细胞高表达CysLT_2受体.LTD_4 1 μmol/L能显著升高C6细胞内钙,其作用约为阳性对照ATP的37 5%.CysLT_2受体拮抗剂抑制LTD_4诱导的C6细胞内钙升高,CysLT_1受体选择性拮抗剂无抑制作用.化合物中DXW-1、2、13、23、29、30能抑制LTD_4诱导的细胞内钙升高.结论:LTD_4诱导的C6细胞的钙信号变化可作为CysLT_2受体拮抗剂的筛选方法;化合物DXW-1、2、13、23、29、30具有CysLT_2受体拮抗活性.
目的:建立半胱氨酰白三烯受體2(CysLT_2受體)拮抗劑篩選的細胞模型及方法,初篩繫列閤成化閤物.方法:選用高錶達CysLT_2受體的大鼠C6膠質瘤細胞,激動劑LTD_4攻擊後檢測細胞內鈣濃度變化,作為CysLT_2受體拮抗劑的篩選方法,初步篩選有拮抗劑活性的化閤物.採用CysLT1/CysLT_2受體非選擇性拮抗劑Bay u9773和CysLT_2受體選擇性拮抗劑AP-100984作為參照.結果:RT-PCR鑒定錶明C6細胞高錶達CysLT_2受體.LTD_4 1 μmol/L能顯著升高C6細胞內鈣,其作用約為暘性對照ATP的37 5%.CysLT_2受體拮抗劑抑製LTD_4誘導的C6細胞內鈣升高,CysLT_1受體選擇性拮抗劑無抑製作用.化閤物中DXW-1、2、13、23、29、30能抑製LTD_4誘導的細胞內鈣升高.結論:LTD_4誘導的C6細胞的鈣信號變化可作為CysLT_2受體拮抗劑的篩選方法;化閤物DXW-1、2、13、23、29、30具有CysLT_2受體拮抗活性.
목적:건립반광안선백삼희수체2(CysLT_2수체)길항제사선적세포모형급방법,초사계렬합성화합물.방법:선용고표체CysLT_2수체적대서C6효질류세포,격동제LTD_4공격후검측세포내개농도변화,작위CysLT_2수체길항제적사선방법,초보사선유길항제활성적화합물.채용CysLT1/CysLT_2수체비선택성길항제Bay u9773화CysLT_2수체선택성길항제AP-100984작위삼조.결과:RT-PCR감정표명C6세포고표체CysLT_2수체.LTD_4 1 μmol/L능현저승고C6세포내개,기작용약위양성대조ATP적37 5%.CysLT_2수체길항제억제LTD_4유도적C6세포내개승고,CysLT_1수체선택성길항제무억제작용.화합물중DXW-1、2、13、23、29、30능억제LTD_4유도적세포내개승고.결론:LTD_4유도적C6세포적개신호변화가작위CysLT_2수체길항제적사선방법;화합물DXW-1、2、13、23、29、30구유CysLT_2수체길항활성.
Objective: To establish a method for screening cysteinyl leukotriene receptor 2 (CysLT_2) antagonists and to preliminarily screen a series of synthetic compounds. Methods: Rat glioma cell line (C6 cells) highly expressing CysLT_2 receptor was used.Intracellular calcium concentration was measured after stimulation with the agonist LTD_4,which was used to screen compounds with antagonist activity for CysLT_2 receptor.Bay u9773,a CysLT_1/CysLT_2 receptor non-selective antagonist,and AP-100984,a CysLT_2 receptor antagonist,were used as control. Results: PT-PCR showed a higher expression of CysLT_2 receptor in C6 cells.LTD_4 at 1 μmol/L significantly increased intracellular calcium in C6 cells;the maximal effect was about 37.5% of ATP,a positive stimulus.LTD_4-induced increase of intracellular calcium was blocked by CysLT_2 receptor antagonists,but not by CysLT_1 receptor antagonists.Among the synthetic compounds,DXW-1,2,13,23,29 and 30 inhibited LTD_4-induced increase of intracellular calcium. Conclusions: LTD_4-induced change in intracellular calcium in C6 cells can be used as a screening method for CysLT_2 receptor antagonists.The compounds,DXW-1,2,13,23,29 and 30,possess antagonist activity for CysLT_2 receptor.